Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 01/17/2025 | CALL | $12.50 | 4 | 0 | |
| 01/17/2025 | CALL | $15.00 | 0 | 0 | |
| 01/17/2025 | CALL | $17.50 | 0 | 0 | |
| 01/17/2025 | CALL | $20.00 | 0 | 0 | |
| 01/17/2025 | CALL | $22.50 | 10 | 0 | |
| 01/17/2025 | CALL | $25.00 | 0 | 0 | |
| 12/19/2025 | PUT | $20.00 | 0 | 0 | |
| 12/19/2025 | PUT | $22.50 | 0 | 0 | |
| 12/19/2025 | PUT | $25.00 | 0 | 0 | |
| 12/19/2025 | PUT | $30.00 | 0 | 0 | |
| 12/19/2025 | PUT | $35.00 | 0 | 0 | |
| 12/19/2025 | PUT | $40.00 | 0 | 0 |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Fidelity Advisor Biotechnology Fund | 3.08% | 807.71k | 14.39M |
| Vanguard Total Stock Market Index Fund | 0.31% | 81.69k | 1.46M |
| Vanguard Extended Market Index Fund | 0.09% | 23.87k | 425.42k |
| Fidelity Extended Market Index Fund | 0.07% | 18k | 320.83k |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.06% | 16.7k | 297.59k |
| iShares Micro Cap ETF | 0.04% | 9.29k | 165.53k |
| Fidelity Total Market Index Fund | 0.03% | 7.72k | 137.55k |
| Bridgeway Funds Inc-Ultra Small Company Fund | 0.03% | 6.97k | 124.29k |
| Fidelity Series Total Market Index Fund | 0.02% | 4.92k | 87.71k |
| Schwab Capital Trust-Total Stock Market Index Fund | 0.01% | 2.88k | 51.32k |
Enliven Therapeutics, Inc. Is a Great Choice for 'Trend' Investors, Here's Why
10/14 03:05 pm
Benzinga
Read moreEnliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
09/28 09:35 am
GlobeNewswire Inc.
Read moreEnliven Therapeutics COO sells over $1.25m in company stock - Investing.com
07/16 06:44 pm
Investing.com
Read moreEnliven Therapeutics to Present at Two Upcoming Investor Conferences
05/29 04:05 pm
GlobeNewswire Inc.
Read moreEnliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update
05/14 04:05 pm
GlobeNewswire Inc.
Read moreEnliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
04/11 10:01 am
Benzinga
Read moreEnliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
04/11 07:55 am
GlobeNewswire Inc.
Read moreEnliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
04/09 04:05 pm
GlobeNewswire Inc.
Read moreEnliven Therapeutics Well-Positioned, With Conservative Trading Levels-Analyst Says
04/09 02:26 pm
Benzinga
Read moreNational CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
03/19 10:03 am
Benzinga
Read moreEnliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
03/14 04:05 pm
GlobeNewswire Inc.
Read moreEnliven Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference
02/27 05:05 pm
GlobeNewswire Inc.
Read moreEnliven Therapeutics Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
08/10 04:05 pm
GlobeNewswire Inc.
Read moreEnliven Therapeutics to Present at Two Upcoming Investor Conferences
05/31 04:55 pm
GlobeNewswire Inc.
Read more3 Stocks in the Limelight on New Analyst Coverage
04/11 07:01 am
Zacks Investment Research
Read moreBenzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
03/29 11:00 am
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For March 3, 2023
03/03 11:00 am
Benzinga
Read more